The global Canine Biopsy Services market size is predicted to grow from US$ 426 million in 2025 to US$ 630 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.

Canine liquid biopsy is a method of analyzing biomarkers in body fluids (such as blood, urine or saliva) to detect the presence of cancer or monitor the progression of cancer. Unlike traditional tissue biopsies, liquid biopsies are non-invasive, fast and convenient. By obtaining a small blood sample, doctors can analyze free DNA, circulating tumor cells, exosomes, etc. to obtain information about the tumor.

United States market for Canine Biopsy Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Canine Biopsy Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Canine Biopsy Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Canine Biopsy Services players cover PetDx, CYTOGEN, BioChain, Small Door, ANGLE, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information) newest research report, the ?Canine Biopsy Services Industry Forecast? looks at past sales and reviews total world Canine Biopsy Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Canine Biopsy Services sales for 2025 through 2031. With Canine Biopsy Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Canine Biopsy Services industry.

This Insight Report provides a comprehensive analysis of the global Canine Biopsy Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Canine Biopsy Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Canine Biopsy Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Canine Biopsy Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Canine Biopsy Services.

This report presents a comprehensive overview, market shares, and growth opportunities of Canine Biopsy Services market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Cut Biopsy
    Needle Biopsy

Segmentation by Application:

    Pet Hospital
    Clinic

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    PetDx
    CYTOGEN
    BioChain
    Small Door
    ANGLE
    BioChain Institute Inc.
    CANCAN DIAGNOSTICS.